GIA
MDCX

Guyasuta Investment Advisors’s Medicus Pharma MDCX Stock Holding History

Guyasuta Investment Advisors’s Portfolio MDCX Stock Details MDCX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-76,911
Closed -$230K – 269
2025
Q2 		$230K Buy
+76,911
New +$307K 0.01% 245

Other funds holding MDCX

ICP
Interchange Capital Partners Pittsburgh, Pennsylvania $532M AUM 26.57% 1-Year Est. Return
YAG
Yorkville Advisors Global Mountainside, New Jersey $86.2M AUM 41.28% 1-Year Est. Return
PAG
Private Advisor Group Morristown, New Jersey $21.8B AUM 28.57% 1-Year Est. Return
WSFS
Wilmington Savings Fund Society Wilmington, Delaware $4.48B AUM 24.77% 1-Year Est. Return
BAM
Brave Asset Management Summit, New Jersey $467M AUM 33.05% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return
MHC
May Hill Capital Cohasset, Massachusetts $479M AUM 31.88% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
BWM
Base Wealth Management Lakewood Ranch, Florida $215M AUM 19.13% 1-Year Est. Return

Guyasuta Investment Advisors's MDCX Position: Q3 2025 in Review

Guyasuta Investment Advisors sold out of Medicus Pharma (MDCX) in Q3 2025, closing a stake of 76,911 shares — an estimated $230K sold.

Guyasuta Investment Advisors first reported a position in MDCX in Q2 2025 and held it in 1 quarter. The position peaked at $230K in Q2 2025. 20 funds tracked by Wall St. Rank hold MDCX as of Q3 2025.

  • Guyasuta Investment Advisors reported no remaining Medicus Pharma position as of Q3 2025 after selling out during the quarter.
  • Guyasuta Investment Advisors sold 76,911 Medicus Pharma shares in Q3 2025, an estimated $230K.
  • Guyasuta Investment Advisors first reported a position in Medicus Pharma in Q2 2025 and held it in 1 quarter.
  • Guyasuta Investment Advisors's Medicus Pharma position peaked at $230K in Q2 2025.
  • 20 funds tracked by Wall St. Rank held Medicus Pharma as of Q3 2025.

Based on Guyasuta Investment Advisors's 13F filing for Q3 2025, filed 21 Oct 2025.